Skip to main content
Clinical Trials/NCT04510103
NCT04510103
Completed
Not Applicable

A Bilateral, Controlled Clinical Trial to Evaluate 2 Different Moisturizer Chassis Formulas for the Relief of Dry Skin

Johnson & Johnson Consumer Inc. (J&JCI)1 site in 1 country46 target enrollmentOctober 23, 2015

Overview

Phase
Not Applicable
Intervention
Moisturizer A, F#9155-005
Conditions
Skin
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI)
Enrollment
46
Locations
1
Primary Endpoint
Mean Change from Baseline to Week 6 in Clinical Grading of Skin Dryness
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Dry skin is characterized by a lack of moisture in the outer layer of the skin and can occur as a result of numerous factors including cold weather, low humidity, age, etc. In this study, the moisturizing benefits of two formulas were evaluated for barrier function improvement/impact when used by women with moderately to severely dry skin on their lower legs.

Registry
clinicaltrials.gov
Start Date
October 23, 2015
End Date
April 7, 2016
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Johnson & Johnson Consumer Inc. (J&JCI)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • moderately to severely dry skin on both leg legs, as determined by the investigator.
  • Fitzpatrick skin types I-IV
  • generally in good health
  • routinely uses moisturizers on the legs at least 1-3 times per week.
  • if of reproductive potential: using a medically acceptable form of birth control for at least 3 months before the study and willing to continue it for at least 1 month after study completion.
  • able to read, write, speak, and understand English.
  • willing and able to complete all study instructions.
  • has completed the informed consent document including a HIPAA disclosure and photograph release.

Exclusion Criteria

  • known allergies/sensitivities to adhesive tapes or study product ingredients.
  • known skin conditions, uncontrolled medical conditions, or any other condition that could interfere with evaluations/data interpretation or increase risk to the subject.
  • any active bacterial/fungal/viral skin infections or susceptibility to such infections.
  • females who are pregnant, breastfeeding, or planning to become pregnant in near future.
  • compromised/broken skin, tattoos, scarring, excessive hair growth, very uneven skin tone, or other conditions that would interfere with evaluations or increase risk to the subject.
  • current participation in another study.
  • participation in another study in past 4 weeks.
  • employees or relatives of the investigator or study site.

Arms & Interventions

Regression Group

The Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then entered a 2-week regression period (no moisturizer usage).

Intervention: Moisturizer A, F#9155-005

Regression Group

The Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then entered a 2-week regression period (no moisturizer usage).

Intervention: Moisturizer B, F#E1387-004

Regression Group

The Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then entered a 2-week regression period (no moisturizer usage).

Intervention: Regression

Non-Regression Group

The Non-Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then underwent a physical insult (tape stripping) on the lower legs and continued using the moisturizer for 4 additional days.

Intervention: Moisturizer A, F#9155-005

Non-Regression Group

The Non-Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then underwent a physical insult (tape stripping) on the lower legs and continued using the moisturizer for 4 additional days.

Intervention: Moisturizer B, F#E1387-004

Non-Regression Group

The Non-Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then underwent a physical insult (tape stripping) on the lower legs and continued using the moisturizer for 4 additional days.

Intervention: Non-Regression

Outcomes

Primary Outcomes

Mean Change from Baseline to Week 6 in Clinical Grading of Skin Dryness

Time Frame: Baseline to Week 6

The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.

Secondary Outcomes

  • Mean Change from Baseline to Week 6 in Clinical Grading of Skin Cracking(Baseline to Week 6)
  • Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Skin Cracking(Regression Baseline to Regression Day 1)
  • Mean Change from Regression Baseline to Regression Day 10 in Clinical Grading of Skin Dryness(Regression Baseline to Regression Day 10)
  • Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Skin Dryness(Regression Baseline to Regression Day 1)
  • Mean Change from Baseline to Week 4 in Clinical Grading of Skin Scaling(Baseline to Week 4)
  • Mean Change from Baseline to Week 4 in Clinical Grading of Skin Dryness(Baseline to Week 4)
  • Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Skin Dryness(Regression Baseline to Regression Day 4)
  • Mean Change from Baseline to Week 2 in Clinical Grading of Skin Cracking(Baseline to Week 2)
  • Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Skin Cracking(Regression Baseline to Regression Day 4)
  • Mean Change from Regression Baseline to Regression Day 14 in Clinical Grading of Skin Cracking(Regression Baseline to Regression Day 14)
  • Mean Change from Baseline to Week 2 in Clinical Grading of Skin Scaling(Baseline to Week 2)
  • Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Skin Scaling(Regression Baseline to Regression Day 4)
  • Mean Change from Regression Baseline to Regression Day 14 in Clinical Grading of Skin Scaling(Regression Baseline to Regression Day 14)
  • Mean Change from Baseline to Week 2 in Clinical Grading of Skin Dryness(Baseline to Week 2)
  • Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Skin Dryness(Regression Baseline to Regression Day 7)
  • Mean Change from Regression Baseline to Regression Day 14 in Clinical Grading of Skin Dryness(Regression Baseline to Regression Day 14)
  • Mean Change from Regression Baseline to Regression Day 10 in Clinical Grading of Skin Cracking(Regression Baseline to Regression Day 10)
  • Mean Change from Baseline to Week 4 in Clinical Grading of Tactile Roughness(Baseline to Week 4)
  • Mean Change from Baseline to Week 4 in Clinical Tolerance Grading(Baseline to Week 4)
  • Mean Change from Baseline to Week 4 in TEWL(Baseline to Week 4)
  • Mean Change from Regression Baseline to Regression Day 4 in Skin Hydration(Regression Baseline to Regression Day 4)
  • Mean Change from Baseline to Week 4 in Clinical Grading of Skin Cracking(Baseline to Week 4)
  • Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Skin Cracking(Regression Baseline to Regression Day 7)
  • Mean Change from Baseline to Week 6 in Clinical Grading of Skin Scaling(Baseline to Week 6)
  • Mean Change from Baseline to Week 2 in Clinical Grading of Tactile Roughness(Baseline to Week 2)
  • Mean Change from Regression Baseline to Regression Day 14 in Clinical Grading of Tactile Roughness(Regression Baseline to Regression Day 14)
  • Mean Change from Baseline to Week 6 in Clinical Tolerance Grading(Baseline to Week 6)
  • Mean Change from Regression Baseline to Regression Day 1 in Clinical Tolerance Grading(Regression Baseline to Regression Day 1)
  • Mean Change from Regression Baseline to Regression Day 7 in Clinical Tolerance Grading(Regression Baseline to Regression Day 7)
  • Mean Change from Regression Baseline to Regression Day 14 in TEWL(Regression Baseline to Regression Day 14)
  • Mean Change from Baseline to Week 4 in NMFs using D-Squames(Baseline to Week 4)
  • Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Skin Scaling(Regression Baseline to Regression Day 1)
  • Mean Change from Regression Baseline to Regression Day 10 in Clinical Grading of Tactile Roughness(Regression Baseline to Regression Day 10)
  • Mean Change from Regression Baseline to Regression Day 10 in Clinical Tolerance Grading(Regression Baseline to Regression Day 10)
  • Mean Change from Regression Baseline to Regression Day 4 in TEWL(Regression Baseline to Regression Day 4)
  • Mean Change from Regression Baseline to Regression Day 1 in Skin Hydration(Regression Baseline to Regression Day 1)
  • Mean Change from Baseline to Week 6 in Skin Flaking using D-Squames(Baseline to Week 6)
  • Mean Change from Baseline to Week 6 in NMFs using D-Squames(Baseline to Week 6)
  • Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Skin Scaling(Regression Baseline to Regression Day 7)
  • Mean Change from Regression Baseline to Regression Day 10 in Clinical Grading of Skin Scaling(Regression Baseline to Regression Day 10)
  • Mean Change from Baseline to Week 6 in Clinical Grading of Tactile Roughness(Baseline to Week 6)
  • Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Tactile Roughness(Regression Baseline to Regression Day 1)
  • Mean Change from Baseline to Week 2 in Clinical Tolerance Grading(Baseline to Week 2)
  • Mean Change from Regression Baseline to Regression Day 4 in Clinical Tolerance Grading(Regression Baseline to Regression Day 4)
  • Mean Change from Regression Baseline to Regression Day 14 in Clinical Tolerance Grading(Regression Baseline to Regression Day 14)
  • Mean Change from Baseline to Week 6 in TEWL(Baseline to Week 6)
  • Mean Change from Regression Baseline to Regression Day 10 in TEWL(Regression Baseline to Regression Day 10)
  • Mean Change from Regression Baseline to Regression Day 14 in Skin Hydration(Regression Baseline to Regression Day 14)
  • Mean Change from Baseline to Week 4 in Epidermal Lipids(Baseline to Week 4)
  • Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Tactile Roughness(Regression Baseline to Regression Day 4)
  • Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Tactile Roughness(Regression Baseline to Regression Day 7)
  • Mean Change from Regression Baseline to Regression Day 1 in TEWL(Regression Baseline to Regression Day 1)
  • Mean Change from Regression Baseline to Regression Day 7 in TEWL(Regression Baseline to Regression Day 7)
  • Mean Change from Baseline to Week 4 in Skin Hydration(Baseline to Week 4)
  • Mean Change from Baseline to Week 6 in Skin Hydration(Baseline to Week 6)
  • Mean Change from Baseline to Week 6 in Epidermal Lipids(Baseline to Week 6)
  • Mean Change from Regression Baseline to Regression Day 7 in Skin Hydration(Regression Baseline to Regression Day 7)
  • Mean Change from Regression Baseline to Regression Day 10 in Skin Hydration(Regression Baseline to Regression Day 10)
  • Mean Change from Baseline to Week 4 in Skin Flaking using D-Squames(Baseline to Week 4)

Study Sites (1)

Loading locations...

Similar Trials